Prospective US investigational device exemption trial of a sutureless aortic bioprosthesis: One-year outcomes
Rakesh M. Suri, Eric E. Roselli(Cleveland Clinic), Gorav Ailawadi(University of Michigan), Robert E. Michler(Albert Einstein College of Medicine), Reza Dabir(Essex Cardiothoracic Centre), Hoda Javadikasgari(Brigham and Women's Hospital), Gabriel S. Aldea(University of Washington), Neil J. Weissman(MedStar Washington Hospital Center), Michael G. Moront(ProMedica Toledo Hospital), Vinod H. Thourani(Valve (United States)), Mark A. Mostovych(St. Vincent's Medical Center), Louis A. Brunsting(University of South Alabama Medical Center), Gregory P. Fontana(HCA Healthcare), Héctor I. Michelena(Mayo Clinic), William F. Kessler(University College Hospital at Westmoreland Street), David Heimansohn, Alvaro Montoya(Baptist Health South Florida), Niv Ad(West Virginia University), Wilson Y. Szeto(Mount Sinai Hospital), Bartley P. Griffith(University of Maryland, Baltimore), Sreekumar Subramanian(Centennial Medical Center)
Cited by 24
Related Papers
Subclinical Thyroid Disease
|JAMA|2004|1.8k
REVERSIBILITY OF LYMPHOMAS AND LYMPHOPROLIFERATIVE LESIONS DEVELOPING UNDER CYCLOSPORIN-STEROID THERAPY
|The Lancet|1984|1.3k
Recommendations for Evaluation of Prosthetic Valves With Echocardiography and Doppler Ultrasound
|Journal of the American Society of Echocardiography|2009|1.3k
Guidelines for Perioperative Care in Cardiac Surgery
|JAMA Surgery|2019|1.2k
Myocardial Viability and Survival in Ischemic Left Ventricular Dysfunction
|New England Journal of Medicine|2011|877